Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -1,097
▲ 79% vs 2024
Profit
Caution€ -28,517
▲ 10% vs 2024
Debts
High€ 258,256
▲ 6% vs 2024
CFG Pharma from Courcelles, company number BE0746821410, closed financial year 2025 with a result of € -28,517 after tax. For that financial year CFG Pharma recorded a gross margin of € -1,097 and equity of € -207,337. Compared with financial year 2024, the result moved from € -31,786 to € -28,517. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
What happened at CFG Pharma?
What happened at CFG Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 28,517. Source: NBB ↗
- CRJ FINANCE SRL became a director. NBB
- NESCH INVEST SRL became a director. NBB
- New establishment in Courcelles. KBO
- Start of the company according to the CBE. KBO
- RXW GROUP SA became a director. NBB
In short
From € 161,954 loss in 2021 to € 28,517 loss in 2025.
A new publication or filing at CFG Pharma? We notify you, reason included.
Follow CFG PharmaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CFG Pharma are RXW GROUP SA, CRJ FINANCE SRL and NESCH INVEST SRL. The same people are also behind EYTELIA, APR Pharma, RXW Group, Nesch Invest and MAB Consult Europe.
Directors
According to the 2025 annual accounts
since 2020
Director · represented by Christiaan Willaert
Also active at: RXW Group, Nesch Invest
since 2023
Director · represented by Geert Van Gijseghem
Also active at: MAB Consult Europe, RXW Group, EPM Pharma Invest +6 more
since 2023
Establishments
Establishment units
Physical locations of this company
Rue de Liège(CO) 2
6180 Courcelles
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Details
- Company number
- 0746.821.410
- VAT number
- BE 0746.821.410
- Registered office
- Rue de Liège(CO) 2, 6180 Courcelles
- Names & denominations
- CFG Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 May 2020
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Overige dienstverlenende activiteiten op het gebied van informatie
Overige zakelijke dienstverlening, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
+2